BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 16682536)

  • 1. Neuropathologic features of amnestic mild cognitive impairment.
    Petersen RC; Parisi JE; Dickson DW; Johnson KA; Knopman DS; Boeve BF; Jicha GA; Ivnik RJ; Smith GE; Tangalos EG; Braak H; Kokmen E
    Arch Neurol; 2006 May; 63(5):665-72. PubMed ID: 16682536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic grain disease in demented subjects presenting initially with amnestic mild cognitive impairment.
    Jicha GA; Petersen RC; Knopman DS; Boeve BF; Smith GE; Geda YE; Johnson KA; Cha R; Delucia MW; Braak H; Dickson DW; Parisi JE
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):602-9. PubMed ID: 16783170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
    Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
    BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
    Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
    Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
    Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Preclinical" AD revisited: neuropathology of cognitively normal older adults.
    Schmitt FA; Davis DG; Wekstein DR; Smith CD; Ashford JW; Markesbery WR
    Neurology; 2000 Aug; 55(3):370-6. PubMed ID: 10932270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology of cognitively normal elderly.
    Knopman DS; Parisi JE; Salviati A; Floriach-Robert M; Boeve BF; Ivnik RJ; Smith GE; Dickson DW; Johnson KA; Petersen LE; McDonald WC; Braak H; Petersen RC
    J Neuropathol Exp Neurol; 2003 Nov; 62(11):1087-95. PubMed ID: 14656067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Delirium With Cognitive Decline in Late Life: A Neuropathologic Study of 3 Population-Based Cohort Studies.
    Davis DH; Muniz-Terrera G; Keage HA; Stephan BC; Fleming J; Ince PG; Matthews FE; Cunningham C; Ely EW; MacLullich AM; Brayne C;
    JAMA Psychiatry; 2017 Mar; 74(3):244-251. PubMed ID: 28114436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.
    Nelson PT; Jicha GA; Schmitt FA; Liu H; Davis DG; Mendiondo MS; Abner EL; Markesbery WR
    J Neuropathol Exp Neurol; 2007 Dec; 66(12):1136-46. PubMed ID: 18090922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathologic alterations in mild cognitive impairment: a review.
    Markesbery WR
    J Alzheimers Dis; 2010; 19(1):221-8. PubMed ID: 20061641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer neuropathologic alterations in aged cognitively normal subjects.
    Davis DG; Schmitt FA; Wekstein DR; Markesbery WR
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):376-88. PubMed ID: 10218633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
    Purohit DP; Perl DP; Haroutunian V; Powchik P; Davidson M; Davis KL
    Arch Gen Psychiatry; 1998 Mar; 55(3):205-11. PubMed ID: 9510214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic basis of age-associated brain atrophy.
    Erten-Lyons D; Dodge HH; Woltjer R; Silbert LC; Howieson DB; Kramer P; Kaye JA
    JAMA Neurol; 2013 May; 70(5):616-22. PubMed ID: 23552688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinician-judged hearing impairment and associations with neuropathologic burden.
    Brenowitz WD; Besser LM; Kukull WA; Keene CD; Glymour MM; Yaffe K
    Neurology; 2020 Sep; 95(12):e1640-e1649. PubMed ID: 32759190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
    Nelson PT; Alafuzoff I; Bigio EH; Bouras C; Braak H; Cairns NJ; Castellani RJ; Crain BJ; Davies P; Del Tredici K; Duyckaerts C; Frosch MP; Haroutunian V; Hof PR; Hulette CM; Hyman BT; Iwatsubo T; Jellinger KA; Jicha GA; Kövari E; Kukull WA; Leverenz JB; Love S; Mackenzie IR; Mann DM; Masliah E; McKee AC; Montine TJ; Morris JC; Schneider JA; Sonnen JA; Thal DR; Trojanowski JQ; Troncoso JC; Wisniewski T; Woltjer RL; Beach TG
    J Neuropathol Exp Neurol; 2012 May; 71(5):362-81. PubMed ID: 22487856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging texture analysis of the corpus callosum and thalamus in amnestic mild cognitive impairment and mild Alzheimer disease.
    de Oliveira MS; Balthazar ML; D'Abreu A; Yasuda CL; Damasceno BP; Cendes F; Castellano G
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):60-6. PubMed ID: 20966061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.